Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million

by Innovation Factory
March 24, 2022

ORIGINAL ARTICLE – Business Wire, March 17, 2022

Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A extension featured new investors, including significant participation from B Capital Group, along with ATEM Capital, the Myeloma Investment Fund, the Multiple Myeloma Research Foundation’s venture philanthropy subsidiary, and others, joined by significant participation from existing investors, Leaps by Bayer, the impact investment unit of Bayer AG, and Northpond Ventures.

The proceeds of the financing will support the continued preclinical and clinical development of Triumvira’s T cell Antigen Coupler (TAC)-T cell therapy programs. Triumvira’s proprietary TAC receptor, a multi-domain chimeric molecule, interacts directly with the natural T cell receptor to uniquely help T cells recognize and eliminate tumor cells. The company’s lead program, TAC01-HER2, is currently being evaluated in a Phase 1/2 clinical trial for patients with HER2-overexpressing solid tumors (TACTIC-2), including breast, gastric, ovarian, pancreatic, gall bladder and non-small cell lung cancers.

To read the full article CLICK HERE.

Original Article on Innovation Factory

Innovation Factory

Innovation Factory is a business accelerator, dedicated to helping Ontario-based businesses launch, scale, and succeed. Supporting the Brant, Halton, Hamilton and Norfolk regions, we provide start-ups, and scaling companies with advisory services, training, mentorship, and strategic connections to help bring disruptive technologies to market, leverage intellectual property, increase revenues, attract investment and create jobs. Innovation can happen anywhere, our goal is to make it work everywhere. We work to elevate key industry sectors including advanced manufacturing, clean tech, information technology, smart transportation, life sciences & health care and social innovations. We are passionate about driving the growth of Ontario businesses like yours. Whether you are an entrepreneur bringing new ideas to market or a scaling business trying to get to the next level, we want to help.